Cytotechnology

, Volume 7, Issue 1, pp 15–24 | Cite as

Growth limitation in hybridoma cell cultures: The role of inhibitory or toxic metabolites

  • Øystein W. Rønning
  • Mona Schartum
  • Andreas Winsnes
  • Gro Lindberg
Original Research Papers

Abstract

Hybridoma cells usually grow to fairly low cell densities in batch cultures (1–3×106 cells/ml). The reason for this is either that essential nutritional components of the medium are consumed, or that the cells produce some kind of inhibitory or toxic metabolite. This investigation presents evidence for the latter. Spent medium from cultures of hybridoma cells did not support growth of cells at lower cell densities (1–3×105 cells/ml). The ability to support cell growth could not be restored by adding additional serum, energy sources (glucose, pyruvate) or L-glutamine. Furthermore, the consumption of amino acids could not account for this growth inhibition. On the contrary, the spent medium contained a substance that inhibited cell growth. This substance or metabolite was found in a fraction eluted from a gel filtration column when spent medium was applied to the column. This substance was found in the spent medium from all hybridoma and myeloma cell lines that were tested. The molecular weight of the substance was about 5 kD. Spent medium from two hybridoma cell lines also contained a substance that was eluted in the same fraction as albumin (67 kD). It is likely that this (or these) substance(s) is responsible for the growth limitation in hybridoma cell cultures.

Key words

hybridoma cells inhibitory or toxic metabolites growth medium gel filtration 

Abbreviations

PBS

phosphate buffered saline

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Butler M and Jenkins H (1989) Nutritional aspects of the growth of animal cells in culture. J. Biotechnol 12: 97–110.Google Scholar
  2. Caroll WL, Thielemans K, Dilley J and Levy R (1986) Mouse x human heterohybridomas as fusion partners with human B cell tumors. J. Immunol. Methods 89: 61–72.Google Scholar
  3. Comer MJ, Kearns MJ, Wahl J, Munster M Lorenz T, Szperalski B, Koch S, Behrendt U and Brunner H (1990) Industrial production of monoclonal antibodies and therapeutic proteins by dialysis fermentation. Cytotechnology 3: 295–299.Google Scholar
  4. Glacken MW, Fleischaker RJ and Sinskey AJ (1986) Reduction of waste product excretion via nutrient control: Possible strategies for maximizing product and cell yields on serum in cultures of mammalian cells. Biotechnol. Bioeng. 27: 1376–1389.Google Scholar
  5. Handa-Corrigan A (1988) Large scale in vitro hybridoma culture: Current status. Biotechnology 6: 784–786.Google Scholar
  6. Kidwell WR (1989) Filtering out inhibition. Biotechnology 7: 462–463.Google Scholar
  7. Kvalhein G, Fodstad Ø, Phil A, Nustad K, Pharo A, Ugelstad J and Funderud S (1987) Elimination of B-lymphoma cells from human bone marrow: Model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer res. 47: 846–851.Google Scholar
  8. Lund A, Hellemann AL and Vartdal F (1988) Rapid isolation of K88+Escherichia coli by using immunomagnetic particles. J. Clin. Microbiol. 26: 2572–2575.Google Scholar
  9. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol Methods 65: 55–63.Google Scholar
  10. Newland M, Greenfield PF and Reid S (1990) Hybridoma growth limitations: The role of energy metabolism and ammonia production. Cytotechnology 3: 215–229.Google Scholar
  11. Rønning ØW and Christophersen (in press) An ELISA-method using magnetic beads as solid phase for rapid quantitation of mouse and human immunoglobulins. Hybridoma.Google Scholar
  12. Rønning ØW and Schartum M (1990) Removal of inhibitory factors from hybridoma cell culture by gel filtration. In: Spier RE, Griffiths JB and Meignier B (eds.) Production of biologicals from animal cell culture. (pp. 218–225) Butterworth-Heinemann Ltd.Google Scholar
  13. Schumpp B and Schlaeger E-J (1989) Physiological studies of high cell density cultures of different cell lines. In: Spier RE, Griffiths JB, Stephenne J and Crooy PJ (eds.) Advances in animal cell biology and technology for bioprocesses. (pp. 224–229) Butterworths & Co Ltd.Google Scholar
  14. Schlaeger E-J and Schumpp B (1989) Studies on mammalian cell growth in suspension culture. In: Spier RE, Griffiths JB, Stephenne J and Crooy PJ (eds.) Advances in animal cell biology and technology for bioprocesses. (pp. 386–397) Butterworths & Co Ltd.Google Scholar
  15. Sjøgren-Jansson E and Jeansson S (1985) Large-scale production of monoclonal antibodies in dialysis tubings. J. Immunol. Methods 84: 359–364.Google Scholar
  16. Thorpe JS, Murdin AD and Spier RE (1987) Waste products affecting hybridoma culture. 194. Am. Chem. Soc. (abstr).Google Scholar
  17. Wagner R, Ryll T, Krafft H and Lehmann (1988) Variation of amino acid concentration in the medium of HU β-IFN and HU IL-2 producing cell lines. Cytotechnology 1: 145–150.Google Scholar

Copyright information

© Kluwer Academic Publishers 1991

Authors and Affiliations

  • Øystein W. Rønning
    • 1
  • Mona Schartum
    • 1
  • Andreas Winsnes
    • 2
  • Gro Lindberg
    • 2
  1. 1.Center for Industrial Research (SI)Oslo 3Norway
  2. 2.Apothekernes Laboratorium A.S.Oslo 2Norway

Personalised recommendations